40
Participants
Start Date
June 16, 2025
Primary Completion Date
September 30, 2029
Study Completion Date
September 30, 2029
MT-401-OTS
MT-401-OTS is an off the shelf cellular therapy product given by IV infusion through either a peripheral or central line.
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
KU Cancer Center, Kansas City
RECRUITING
City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Lead Sponsor
University of Kansas Medical Center
OTHER
H. Lee Moffitt Cancer Center and Research Institute
OTHER
City of Hope National Medical Center
OTHER
Marker Therapeutics, Inc.
INDUSTRY